[The treatment of nasal (nasal-type) NK-T cell lymphoma].
OBJECTIVE
To discuss the treatment of nasal (nasal-type) NK-T cell lymphoma.


METHODS
From 1993 to 2000, there were twenty one nasal (nasal-type) NK-T cell lymphoma patients treated in our department, three patients were treated with only radiotherapy, eighteen patients were treated combination radiotherapy with chemotherapy, and all patients were followed up for 1-8 years.


RESULTS
Eleven patients completely alleviated, six patients partial alleviated, four aggravated and two died.


CONCLUSIONS
The prognosis of nasal (nasal-type) NK-T cell lymphoma is not satisfactory. The combination therapy for it is the optimal at present.
Wang
Canmin
C
Department of Otolaryngology, Changhai Hospital, Second Military Medical University, Shanghai 200433.
Zhang
Suqin
S
Li
Zhaoji
Z
D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007694:Killer Cells, Natural; D016399:Lymphoma, T-Cell / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009669:Nose Neoplasms / Q000628:therapy*